Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
26°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BMRN
Recent news which mentions BMRN
< Previous
1
2
3
4
5
Next >
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
Tickers
ALNY
AMGN
AZN
BIIB
Tags
ALNY
AMGN
IONS
From
InvestorPlace
Why BioMarin Pharmaceutical Tumbled on Thursday
February 24, 2022
Tickers
BMRN
Tags
BMRN
Recent Press Releases
Market News
From
Motley Fool
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Tickers
ABCL
ADGI
AGIO
ARYD
Tags
EBS
FLGT
OTIC
From
Benzinga
BioMarin Clocks Flat Q4 Sales Despite Erosion oF US Kuvan Market
February 24, 2022
Tickers
BMRN
SNY
Tags
Guidance
Health Care
BMRN
From
Benzinga
Recap: Biomarin Pharmaceutical Q4 Earnings
February 23, 2022
Tickers
BMRN
Tags
BMRN
Market News
Benzinga
From
Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Tickers
AKBA
ARNA
AVNS
BHC
Tags
NVRO
BHC
Benzinga
From
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Tickers
ABCL
AGIO
ARNA
ATXI
Tags
KDNY
Small Cap
PTCT
From
Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
February 18, 2022
Tickers
BMRN
Tags
General
FDA
News
From
Benzinga
BioMarin Sells Priority Review Voucher For $110M
February 09, 2022
Tickers
BMRN
Tags
General
FDA
News
From
Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
Tickers
ADGI
ALLK
ALNY
ARGX
Tags
ADGI
DNLI
MRTX
From
MarketWatch
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
January 10, 2022
Tickers
BMRN
Tags
BMRN
Health Care
Biotech
From
Benzinga
2 Under-the-Radar Biotech Picks to Buy For The Long Haul
December 24, 2021
Tickers
BMRN
CORT
CPRX
Tags
CORT
BMRN
CPRX
From
Motley Fool
This Favorable Sign Appears On Biomarin Pharmaceutical's Chart
November 25, 2021
Tickers
BMRN
Tags
Benzinga
Movers
Trading Ideas
From
Benzinga
Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart
November 24, 2021
Tickers
BMRN
Tags
Markets
BMRN
Market News
From
Benzinga
Where Biomarin Pharmaceutical Stands With Analysts
November 22, 2021
Tickers
BMRN
Tags
Benzinga
Analyst Ratings
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021
November 22, 2021
Tickers
ADBE
AIP
ALNY
ASPU
Tags
BLNK
AUY
FHTX
From
Benzinga
10 Biggest Price Target Changes For Monday
November 22, 2021
Tickers
ALNY
AMGN
ATVI
BMRN
Tags
Benzinga
ATVI
ALNY
From
Benzinga
Why BioMarin Pharmaceutical Stock Jumped by 10.3% on Friday
November 20, 2021
Tickers
BMRN
Tags
Recent Press Releases
Market News
BMRN
From
Motley Fool
FDA Conditionally Approves Biomarin's Dwarfism Drug
November 19, 2021
Tickers
BMRN
Tags
News
Briefs
FDA
From
Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
Trading Ideas
VRTX
NVS
From
Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
Tickers
ACRX
AMRN
ATHX
AYTU
Tags
PAVM
BIOC
TFFP
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
Tickers
AADI
AMYT
BMRN
BYSI
Tags
Benzinga
ETON
UTHR
From
Benzinga
BioMarin's Q3 Net Income Hit By Lower Product Sales
October 28, 2021
Tickers
BMRN
Tags
News
Briefs
General
From
Benzinga
BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript
October 28, 2021
Tickers
BMRN
Tags
Market News
BMRN
From
Motley Fool
Biomarin Pharmaceutical: Q3 Earnings Insights
October 27, 2021
Tickers
BMRN
Tags
Benzinga
Earnings
BZI/Recaps
From
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Tickers
ABBV
ADAP
ALIM
ALKS
Tags
Small Cap
BMY
MRK
From
Benzinga
2 Upcoming FDA Approval Decisions That Investors Should Really Watch
October 23, 2021
Tickers
BLUE
BMRN
BMY
JNJ
Tags
LEGN
BMY
JNJ
From
Motley Fool
The Smartest Stocks to Buy With $250 Right Now
October 22, 2021
Tickers
BMRN
FRPT
GRWG
Tags
Market News
GRWG
BMRN
From
Motley Fool
Barron's Latest Picks And Pans: Amazon, Apple, Chevron, Citigroup, Dell And More
October 16, 2021
Tickers
AAPL
AMZN
BMRN
C
Tags
BMRN
VMW
TDG
From
Benzinga
Stifel Upgrades This Pharma Stock On Prospective FDA Approval For Dwarfism Drug
September 09, 2021
Tickers
BMRN
Tags
Health Care
Movers
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.